b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">30496913</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>20</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1557-8615</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>50</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>04</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of critical care</Title>\n                <ISOAbbreviation>J Crit Care</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>69-76</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0883-9441(18)30580-X</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2018.11.016</ELocationID>\n            <Abstract>\n                <AbstractText Label="PURPOSE">To assess the pharmacokinetics of linezolid in septic patients undergoing continuous renal replacement therapy (CRRT) and investigate whether residual renal function affects the probability of attaining the pharmacokinetic/pharmacodynamic (PK/PD) target.</AbstractText>\n                <AbstractText Label="MATERIAL AND METHODS">Prospective study conducted in three Spanish hospitals. Linezolid concentrations were measured in plasma and effluent samples and pharmacokinetic parameters were calculated. The probability of target attainment (PTA) and the cumulative fraction of response (CFR) were calculated considering AUC<sub>24</sub>/MIC&gt;80 and %T<sub>&gt;MIC</sub>\xe2\x80\xaf&gt;\xe2\x80\xaf85% as the PK/PD indexes related to efficacy.</AbstractText>\n                <AbstractText Label="RESULTS">In anuric patients (CrCl&lt;10\xe2\x80\xafmL/min), the contribution of extracorporeal Cl to total Cl was higher (47% vs 16%) than in patients with residual renal function (CrCl\xe2\x89\xa510\xe2\x80\xafmL/min). For an MIC of 2\xe2\x80\xafmg/L, AUC<sub>24</sub>/MIC&gt;80 was achieved in &gt;85% of the anuric patients, but in &lt;15% of the patients with residual renal function.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">The standard dose (600\xe2\x80\xafmg q12h) ensures a moderately high probability of treatment success in anuric patients when the infection is due to microorganisms with MIC\xe2\x89\xa42\xe2\x80\xafmg/L; although higher doses increase the probability of treatment success, the safety is compromised. In patients with residual renal function, the standard dose is insufficient, but 900\xe2\x80\xafmg q8h provide higher probability of treatment success without compromising the safety.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Barrasa</LastName>\n                    <ForeName>Helena</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Intensive Care Unit, University Hospital Araba C/ Olaguibel n\xc2\xb0 29, Vitoria-Gasteiz, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Soraluce</LastName>\n                    <ForeName>Amaia</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmacokinetics, Nanotechnology and Gene Therapy Group, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad n\xc2\xb0 7, Vitoria-Gasteiz, Spain; Centro de Investigaci\xc3\xb3n Lascaray ikergunea, University of the Basque Country UPV/EHU, Avenida Miguel de Unamuno, 3, Vitoria-Gasteiz, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Isla</LastName>\n                    <ForeName>Arantxazu</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmacokinetics, Nanotechnology and Gene Therapy Group, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad n\xc2\xb0 7, Vitoria-Gasteiz, Spain; Centro de Investigaci\xc3\xb3n Lascaray ikergunea, University of the Basque Country UPV/EHU, Avenida Miguel de Unamuno, 3, Vitoria-Gasteiz, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mart\xc3\xadn</LastName>\n                    <ForeName>Alejandro</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Intensive Care Unit, University Hospital Araba C/ Olaguibel n\xc2\xb0 29, Vitoria-Gasteiz, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Maynar</LastName>\n                    <ForeName>Javier</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Intensive Care Unit, University Hospital Araba C/ Olaguibel n\xc2\xb0 29, Vitoria-Gasteiz, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Canut</LastName>\n                    <ForeName>Andr\xc3\xa9s</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Microbiology Service, University Hospital Araba, C/ Francisco Leandro de Viana n\xc2\xb0 1, Vitoria-Gasteiz, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>S\xc3\xa1nchez-Izquierdo</LastName>\n                    <ForeName>Jos\xc3\xa9 Angel</ForeName>\n                    <Initials>JA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Intensive Care Unit, Doce de Octubre Hospital, Avda de C\xc3\xb3rdoba s/n, Madrid, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rodr\xc3\xadguez-Gasc\xc3\xb3n</LastName>\n                    <ForeName>Alicia</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmacokinetics, Nanotechnology and Gene Therapy Group, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad n\xc2\xb0 7, Vitoria-Gasteiz, Spain; Centro de Investigaci\xc3\xb3n Lascaray ikergunea, University of the Basque Country UPV/EHU, Avenida Miguel de Unamuno, 3, Vitoria-Gasteiz, Spain. Electronic address: alicia.rodriguez@ehu.eus.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>17</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>J Crit Care</MedlineTA>\n            <NlmUniqueID>8610642</NlmUniqueID>\n            <ISSNLinking>0883-9441</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>ISQ9I6J12J</RegistryNumber>\n                <NameOfSubstance UI="D000069349">Linezolid</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>MU72812GK0</RegistryNumber>\n                <NameOfSubstance UI="D003401">Creatine</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>\n                <QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000079664" MajorTopicYN="Y">Continuous Renal Replacement Therapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003401" MajorTopicYN="N">Creatine</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000069349" MajorTopicYN="N">Linezolid</DescriptorName>\n                <QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009010" MajorTopicYN="N">Monte Carlo Method</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Continuous renal replacement therapy</Keyword>\n            <Keyword MajorTopicYN="Y">Critically ill patients</Keyword>\n            <Keyword MajorTopicYN="Y">Linezolid</Keyword>\n            <Keyword MajorTopicYN="Y">Pharmacokinetic/pharmacodynamics</Keyword>\n            <Keyword MajorTopicYN="Y">Residual renal function</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>04</Month>\n                <Day>24</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>14</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>30</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>30</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30496913</ArticleId>\n            <ArticleId IdType="pii">S0883-9441(18)30580-X</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jcrc.2018.11.016</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'